$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare Q1 Earnings Call Highlights
10:06pm, Friday, 08'th May 2026
Sensus Healthcare NASDAQ: SRTS said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
11:18am, Friday, 08'th May 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, tod
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
08:01am, Friday, 08'th May 2026
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
04:05pm, Thursday, 07'th May 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
05:56pm, Thursday, 23'rd Apr 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological
Sensus Healthcare (NASDAQ:SRTS) versus Adagio Medical (NASDAQ:ADGM) Head to Head Contrast
01:44am, Friday, 17'th Apr 2026
Sensus Healthcare (NASDAQ: SRTS - Get Free Report) and Adagio Medical (NASDAQ: ADGM - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two c
Brokerages Set Sensus Healthcare, Inc. (NASDAQ:SRTS) PT at $6.88
03:17am, Monday, 30'th Mar 2026
Sensus Healthcare, Inc. (NASDAQ: SRTS - Get Free Report) has received an average rating of "Moderate Buy" from the six ratings firms that are currently covering the firm, MarketBeat reports. One equit
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
08:00am, Friday, 27'th Mar 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
08:00am, Thursday, 26'th Feb 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
08:30am, Wednesday, 18'th Feb 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
Sensus Healthcare, Inc. (SRTS) Q4 2025 Earnings Call Transcript
11:14pm, Thursday, 12'th Feb 2026
Sensus Healthcare, Inc. (SRTS) Q4 2025 Earnings Call Transcript
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea
Sensus Healthcare (SRTS) Expected to Announce Earnings on Wednesday
03:28am, Wednesday, 28'th Jan 2026
Sensus Healthcare (NASDAQ: SRTS - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of
Sensus Healthcare (NASDAQ:SRTS) vs. Envoy Medical (NASDAQ:COCH) Financial Contrast
03:10am, Sunday, 18'th Jan 2026
Envoy Medical (NASDAQ: COCH - Get Free Report) and Sensus Healthcare (NASDAQ: SRTS - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two co
Sign In
Buy SRTS